Molecular and clinical delineation of the 17q22 microdeletion phenotype by Laurell, T, Lundin, J, Nordenskjöld, A, Anderlid, B, Grigelioniene, G, Nordgren, A, Gorski, J, Knight, S, Krepischi, A, Price, S, Rosenberg, C, Vianna-Morgante, A, Turnpenny, P

Molecular and clinical delineation of the 17q22 microdeletion phenotype. by Laurell, T, Lundin, J, Anderlid, B, Gorski, J, Grigelioniene, G, Knight, S, Krepischi, A, Nordenskjöld, A, Price, S, Rosenberg, C, Turnpenny, P, Vianna-Morgante, A, Nordgren, A

Clinical and molecular consequences of disease-associated de novo mutations in SATB2 by Bengani, H, Handley, M, Alvi, M, Ibitoye, R, Lees, M, Lynch, S, Lam, W, Fannemel, M, Nordgren, A, Malmgren, H, Kvarnugn, M, Mehta, S, McKee, S, Whiteford, M, Stewart, F, Connell, F, Clayton-Smith, J, Mansour, S, Mohammed, S, Fryer, A, Morton, J, UK10K Consortium, Grozeva, D, Asam, T, Moore, D, Sifrim, A, McRae, J, Hurles, M, Firth, H, Raymond, F, Kini, U, Nellaker, C, DDD Study, FitzPatrick, D